Format:
Online-Ressource (XII, 406p. 34 illus., 21 illus. in color, digital)
ISBN:
9789400719835
Series Statement:
Evidence-based Anticancer Complementary and Alternative Medicine 2
Content:
Cancer is one of the leading killers in the world and the incidence is increasing, but most cancer patients and cancer survivors suffer much from the disease and its conventional treatments' side effects. In the past, clinical data showed that some complementary and alternative medicine (CAM) possessed anticancer abilities, but some clinicians and scientists have queried about the scientific validity of CAM due to the lack of scientific evidence. There is great demand in the knowledge gap to explore the scientific and evidence-based knowledge of CAM in the anticancer field. With this aim, a bo
Note:
Description based upon print version of record
,
Materia Medica for Various Cancers; Preface; Contents; Contributors; Chapter 1: Evidence-based Anticancer Materia Medica for Lung Cancer; 1.1 Introduction; 1.1.1 Incidence of Lung Cancer; 1.1.2 Overview of Management; 1.1.3 SCLC; 1.1.4 NSCLC; 1.2 The Application of Herbal Medicine for Lung Cancer Treatment; 1.2.1 Experimental and Preclinical Studies on Herbal Medicine Treatment in Lung Cancer; 1.2.2 Clinical Trials on Lung Chemoprevention; 1.2.3 Systematic Review and Meta-analysis on Herbal Medicine as Adjuvant to Lung Cancer Treatment
,
1.3 Herb-drug Interaction, Safety, Toxicity, and Adverse Effect1.4 Herbal Medicine's Anticancer Mechanisms for Lung Cancer; 1.5 Future Perspectives; References; Chapter 2: Evidence-based Anticancer Materia Medica for Colorectal Cancer; 2.1 Introduction; 2.2 Herbal Medicine; 2.2.1 Ginseng; 2.2.2 PHY906; 2.2.3 Rhus verniciflua Stokes; 2.2.4 Curcumin; 2.2.5 Thymoquinone; 2.2.6 Genistein; 2.2.7 Other Herbal Products; 2.3 Clinical Studies; References; Chapter 3: An Overview of the Current Development of Phytoremedies for Breast Cancer; 3.1 Current Status of Breast Cancer and Barriers to Treatment
,
3.2 Current Research into and Development of Phytoagents for Breast Cancer Treatment3.2.1 Phenolic Compounds; 3.2.1.1 Curcumin; 3.2.1.2 (-)-Epigallocatechin-3-Gallate (EGCG); 3.2.1.3 Genistein; 3.2.1.4 Silymarin; 3.2.2 Terpenoids; 3.2.2.1 Sesquiterpene Lactones (SLs); 3.2.2.2 Monoterpenes and Diterpenes; 3.2.3 Alkaloids; 3.2.3.1 Quinolone Alkaloids; 3.2.3.2 Isoquinoline Alkaloids; 3.2.3.3 Benzophenanthridine Alkaloids; 3.2.4 Other Plant Natural Products; 3.2.4.1 Emodin; 3.2.4.2 Ginsenosides; 3.2.4.3 Isothiocyanates; 3.2.5 Traditional Chinese Medicine; 3.3 Conclusions and Future Prospects
,
ReferencesChapter 4: Evidence-based Anticancer Kampo Medicine for Gastric Cancer; 4.1 Introduction; 4.2 Kampo Medicine for Postoperative Symptoms; 4.2.1 Rikkunshito for Delayed Gastric Empting After PPG; 4.2.2 Daikenchuto After Total Gastrectomy with Jejunal Pouch Reconstruction; 4.3 Kampo Medicines for Side Effects of Chemotherapy; 4.3.1 Cisplatin-induced Anorexia; 4.3.2 CPT-11-induced Delayed Diarrhea; 4.3.3 Paclitaxel-induced Peripheral Neuropathy; 4.4 Antitumor Effect of Kampo Medicines; 4.5 Chemoprevention of Gastric Cancer by Kampo Medicines; 4.6 Conclusion; References
,
Chapter 5: Evidence-based Anticancer Materia Medica for Hepatocellular Carcinoma5.1 Introduction; 5.2 Mechanisms of Action; 5.2.1 Inhibition of Precancerous Lesions; 5.2.2 Inhibition of HCC Proliferation and the Induction of Apoptosis Therein; 5.2.3 Induction of Differentiation in HCC; 5.2.4 Regulation of Immune Responses; 5.2.5 Inhibition of Angiogenesis and Metastasis; 5.2.6 Reversal of Multiple-drug Resistance; 5.2.7 Targeting Epigenetic Regulation; 5.3 Clinical Efficacies; 5.4 Conclusions; References; Chapter 6: Evidence-based Anticancer Materia Medica for Prostate Cancer
,
6.1 The Prostate Gland and Prostate Cancer
Additional Edition:
ISBN 9789400719828
Additional Edition:
Buchausg. u.d.T. ISBN 978-94-007-1982-8
Language:
English
DOI:
10.1007/978-94-007-1983-5
URL:
Volltext
(lizenzpflichtig)
Bookmarklink
